Develops and patents a unique method for producing allogeneic natural killer (NK) cells from induced pluripotent stem cells using engineered bioreactors, advancing research in regenerative medicine and immuno-oncology. The team consists of leading experts in stem cell biology and experienced entrepreneurs.